
Tiziana Life Sciences Ltd (TLSA)
US$ 1.36-5.56%
Price Chart
Key Statistics
Market Cap
$ 168.26M
P/E Ratio
0.00
Revenue (TTM)
$ -3.6M
Volume
342.93K
52W High
$ 1.91
52W Low
$ 0.54
Dividend Yield
0.00%
Beta
0.16
Technicals
50-Day MA
1.1294
200-Day MA
0.9787
52 Week High
1.91
52 Week Low
0.5437
About TLSA
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology in the United States. The company's lead pr.
Employees
9
Headquarters
London, United Kingdom
CEO
Mr. Gabriele Marco Antonio Cerrone M.B.A.
Latest News
Why Tiziana Life Sciences Ltd (TLSA) is Skyrocketing So Far in 2025 - Yahoo Finance
2025-03-02 • Google News
Tiziana Life Sciences (TLSA) Expands Clinical Trial for MS Treat - GuruFocus
5 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg